S-Space

Browse

Subject

Showing results 1 to 4 of 4

Issue Date	Title / Author(s) / Citation	File
2005-06	Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers Chung, Jae-Yong; Cho, Joo-Youn; Yu, Kyung-Sang; Kim, Jung-Ryul; Jung, Hye-Ryung; Lim, Kyoung-Soo; Jang, In-Jin; Shin, Sang-Goo Clin Pharmacol Ther. 2005 Jun;77(6):486-94.	link
2006-04	Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin Han, J. Y.; Lim, H. S.; Shin, E. S.; Yoo, Y. K.; Park, Y. H.; Lee, J. E.; Jang, I. J.; Lee, D. H.; Lee, J. S. J Clin Oncol. 2006 May 20;24(15):2237-44. Epub 2006 Apr 24.	view file link
2007-08	Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects Chung, J. Y.; Cho, J. Y.; Yu, K. S.; Kim, J. R.; Lim, K. S.; Sohn, D. R.; Shin, S. G.; Jang, I. J. Clin Pharmacol Ther. 2008 Apr;83(4):595-600. Epub 2007 Aug 8.	link
2007-08	Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects Chung, J-Y; Cho, J-Y; Yu, K-S; Kim, J-R; Lim, K S; Sohn, D-R; Shin, S-G; Jang, I-J Clin Pharmacol Ther. 83(4):595-600	link